Sarcoma Mid-Therapy [F-18]Fluorodeoxyglucose Positron Emission Tomography (FDG PET) and Patient Outcome

BACKGROUND: Our previous research investigated the ability of [F-18]fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging results to predict outcome in patients with sarcoma. Tumor uptake of FDG before and after neoadjuvant chemotherapy was predictive of patient outcome. With this back...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Eary, Janet F., Conrad, Ernest U., O’Sullivan, Janet, Hawkins, Douglas S., Schuetze, Scott M., O’Sullivan, Finbarr
Format: Artigo
Jezik:Inglês
Izdano: Journal of Bone and Joint Surgery, Inc. 2014
Teme:
Scientific Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3903137/
https://ncbi.nlm.nih.gov/pubmed/24430415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2106/JBJS.M.00062
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items